Skip to main content

Security report for abf-pharma.com

ABF Pharmaceutical Services GmbH · Healthcare · Austria

Medium risk. 4 critical or high findings in GDPR outside view and SSL/TLS.

Security score

55/100

Risk levelMedium

0–100, higher is better. How it is calculated

ABF Pharmaceutical Services GmbH, part of the GBA Group, specializes in providing comprehensive logistical support for clinical trials, including GMP-certified pharmaceutical services such as kit production, labeling, packaging, storage, and distribution. The company operates internationally with a strong presence in Europe, the USA, and Asia, serving pharmaceutical and biotechnology companies. Their technical infrastructure is modern, leveraging React and Gatsby frameworks hosted on Netlify, with content managed via Storyblok CMS. However, the website lacks a valid SSL/TLS certificate, which significantly impacts its security posture. While security headers are present, the absence of HTTPS and modern TLS protocols exposes the site to risks. Privacy compliance is partially addressed with a cookie consent mechanism but lacks comprehensive GDPR indicators. Overall, the business credibility is strong, supported by clear contact information, certifications, and consistent WHOIS data. Strategic improvements in SSL configuration and security policies are recommended to enhance trust and compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
18/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

Need hands-on remediation? Email guard@offseq.com

Keep watching abf-pharma.com

This scan found 15 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
80
Email security
50
DNS health
80
Network security
100
GDPR outside view
18
Average
55

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company holds a mature domain and is registered in Austria, consistent with its stated headquarters. It offers a wide range of clinical trial supply services, including specialized laboratory capabilities for PBMC isolations. The business model focuses on service provision to pharmaceutical and biotech sectors, with a reliable international distribution network. The website reflects good branding consistency and professional content, targeting industry professionals. The presence of social media channels and membership in the GBA Group enhances its market positioning. No suspicious patterns were detected in domain registration or website content.

Security posture

The website demonstrates basic security best practices with several security headers configured. However, the critical lack of a valid SSL certificate and disabled TLS protocols severely undermine the security posture. No incident response or vulnerability disclosure policies are found, indicating potential gaps in security governance. The cookie consent mechanism is implemented, but GDPR compliance is not fully evident. Recommendations include immediate SSL deployment, enabling modern TLS versions, and publishing security policies to improve resilience and compliance.

Recommendations

  1. Obtain and deploy a valid SSL/TLS certificate to enable HTTPS across the site.
  2. Enable and configure modern TLS protocols (TLS 1.2 and TLS 1.3) and related SSL optimizations such as OCSP stapling.
  3. Publish explicit security policies including incident response and vulnerability disclosure to enhance transparency.
  4. Enhance GDPR compliance by providing a comprehensive privacy policy and data protection officer contact details.
  5. Regularly audit and update security headers and cookie consent mechanisms to align with best practices.

Contact details published on the site

Addresses
Legal name
ABF Pharmaceutical Services GmbH
Technical notes

Notes

The website is built using modern web technologies including React and Gatsby, hosted on Netlify, and uses Storyblok as a CMS. The site is mobile optimized with good SEO practices and structured content. However, performance metrics are missing or zero, indicating potential issues with load time measurement or optimization. Accessibility is basic but could be improved. The lack of HTTPS and SSL configuration is a significant technical risk. The site uses Cookiebot for cookie consent management, indicating awareness of privacy requirements. Overall, the technical infrastructure is modern but requires security enhancements and performance tuning.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with abf-pharma.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review abf-pharma.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.